The largest database of trusted experimental protocols

Celltiter glo 3d cell viability assay kit

Manufactured by Promega
Sourced in United States, Japan

The CellTiter-Glo 3D Cell Viability Assay kit is a luminescent cell viability assay that quantifies the amount of ATP present in metabolically active cells. It provides a homogeneous method to determine the number of viable cells in 3D cell culture.

Automatically generated - may contain errors

41 protocols using celltiter glo 3d cell viability assay kit

1

Quantification of Albumin Secretion

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure ALB production, 100 μl of culture medium was collected from each group and quantified using an enzyme-linked immunosorbent assay kit (Bethyl Laboratories, Montgomery, TX, USA) according to the manufacturer’s protocol. The total ALB concentration was normalized to the total adenosine triphosphate (ATP) content of each sample using a CellTiter-Glo 3D cell viability assay kit (Promega, Madison, WI, USA).
+ Open protocol
+ Expand
2

Spheroid Viability Assay with RSL3 and Fer1

Check if the same lab product or an alternative is used in the 5 most similar protocols
K1 cells were incubated to form spheroids (~ 7 days) in ultra-low binding 96-well plates for viability assay and in ultra-low binding 24-well plate for imaging with PI staining. Spheroids were treated with RSL3 and Fer1 for 48 h. Viability of spheroids were determined using CellTiter-Glo 3D cell viability assay kit (Promega). To visualize cell death in the spheroids. 20 μg of propidium iodide (PI) was added for 30 min and microscopic images were taken using Keyence Fluorescent Microscope BZ-X800.
+ Open protocol
+ Expand
3

siRNA Screen for Cisplatin Sensitivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
TGCT-PDC and TGCT-PDC-R cells were seeded at 10,000 cells/well in 96‐well plates and simultaneously transfected with indicated siRNAs at a final concentration of 30 nM using Lipofectamine RNAiMAX reagent (Invitrogen). Six hours after transfection, medium was added to increase the concentration of cisplatin to 0.2 µM. Cell viability was measured by quantitation of intracellular ATP content using CellTiter-Glo 3D Cell Viability Assay Kit (Promega) at 96 h after transfection. After 30 min of cell lysis, chemiluminescent values were measured using the TriStar2 S LB 942 Multimode Reader (Berthold Technologies). NEC8 and NEC8-R cells were seeded at 2,000 cells/well in 96‐well plates and 24 h later transfected with indicated siRNAs at a final concentration of 10 nM using Lipofectamine RNAiMAX reagent. Twenty-four hours after transfection, medium was added to increase the concentration of cisplatin to 1.0 µM. At 72 h after transfection, 10 μL of a Cell Count Reagent SF, a reagent containing 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt (WST-8) (Nacalai Tesque) was added to each well and the cells were incubated for 4 h at 37 °C. Absorbance of the plates was read on Multiskan FC Photometer (Thermo scientific) at a wavelength of 450 nm.
+ Open protocol
+ Expand
4

Spheroid Formation Assay with Chemotherapies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three thousand Accumax-dispersed single cells per well were seeded in ultra-low attachment plates (Corning). To examine the effect of ribavirin and chemotherapy on spheroid formation, 100 μM ribavirin, 10 nM docetaxel, 10 nM cabazitaxel or vehicle was added to the medium. Spheroid cell viability was evaluated using Cell titer-Glo 3D Cell Viability Assay kit (Promega, Madison, WI) using an automatic luminometer (N = 4). Chemiluminescence values were normalized with the vehicle-treated samples.
+ Open protocol
+ Expand
5

Cytotoxicity Assay of 2-ClHDyA and 2-ClHDA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, HL-1 cells were seeded in 96 well plates and incubated in the presence of the indicated concentrations of 2-ClHDyA and 2-ClHDA (in DMSO). At the indicated time points, cell viability was measured using CellTiter-Glo® 3D cell viability assay kit (Promega) according to the manufacturer’s recommendations. The CellTiter-Glo assay detects ATP as an indicator of cell viability [76 (link)].
+ Open protocol
+ Expand
6

Measuring Ferroptotic Cell Death

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze ferroptotic cell death, cell viability was measured using the CellTiter-Glo 3D Cell Viability Assay kit (Promega). Briefly, we plated the cells in white-walled 96-well plates (Falcon) at the density of 1.0 × 104 cells/well and treated the cells with ferroptosis inducers and/or inhibitors for 24 hours. After the treatment, one volume of the CellTiter-Glo 3D reagent was added into each well, mixed on a thermomixer at 750 rpm for 5 minutes, and then incubated at room temperature for another 20 minutes. The luminance signal for a 250-millisecond integration time was measured using a SpectraMax M3 Multi-Mode Microplate Reader (Molecular Devices).
+ Open protocol
+ Expand
7

HeLa Cell Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were maintained as described in the General Tissue Culture Methods section. After trypsinization and counting, cells were distributed into the wells of a 96-well plate with media containing the indicated concentration of the synthetic compound and 1% DMSO (or DMSO alone) at 5,000 cells per well. After 20 h, cell viability was determined using the CellTiter-Glo 3D Cell Viability Assay kit (Promega) following the manufacturer’s instructions and measuring luminescence on a Bio-Tek Synergy HTX multimode plate reader.
+ Open protocol
+ Expand
8

3D Cell Culture Viability Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 2000 cells per well in a 96-well U-bottom plate (#353077, Corning). The 3D cell culture media was a mixture of the media for 2D cell culture supplemented with 10% Matrix (#A1413201, Thermo Scientific). On day 6, sphere colonies were firstly observed under microscope and images were taken using Leica microscope with X 5 bright field objective. The length and width for each spheroid were measured afterwards in Image J (v1.53k). The viability for spheroids was determined by CellTiter-Glo® 3D Cell Viability Assay Kit (#G9681, Promega). Briefly, 100 μl CellTiter-Glo® 3D Reagent was added into the wells to be determined, followed by shaking for 5 min. After incubation at room temperature for 25 min, the plate was read on the luminometer plate reader (Promega). The luminescence signals were measured and collected for evaluating the 3D cell growth viability.
+ Open protocol
+ Expand
9

NDMA Cytotoxicity Evaluation in 2D and 3D

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity was evaluated with the CellTiter-Glo ATP-based assay on Day 1, Day 2, and Day 3 following 24-, 48-, and 72-h of NDMA treatments, respectively (Fig. 1B). The reagent in the CellTiter-Glo Luminescent Cell Viability Assay kit (Cat# G7572, Promega; Madison, WI) for 2D cultures or the CellTiter-Glo 3D Cell Viability Assay kit (Cat# G9683, Promega) for 3D spheroids was added to wells of the 96-well plate at a ratio of 1:10. One spheroid per well was used for the 3D ATP assay. Following a 10-min incubation at room temperature, luminescence was measured with a Cytation 5 Cell Imaging Multi-Mode Reader (BioTek, Winooski, VT). The relative cell viability was expressed as the percentage of luminescent signal produced by the treated cells as compared to the untreated control cells.
+ Open protocol
+ Expand
10

Evaluating PDTO Viability with CellTiter-Glo

Check if the same lab product or an alternative is used in the 5 most similar protocols
Upon treatment with either belinostat or Cubisbel, PDTO viability was evaluated using the CellTiter-Glo 3D Cell Viability Assay kit (Promega, #G9681). Briefly, the reagent was thawed at 4°C overnight, and equilibrated to RT in a 22°C water bath prior to use for 30 min. For assays, the 96-well plates containing PDTOs were equilibrated to RT for approximately 30 min. For each well, 100 µl of reagent was added and the contents were vigorously mixed for 5 min to induce cell lysis. Then, the plates were incubated for an additional 25 min to stabilize the luminescent signal. Finally, luminescence was recorded using a plate reader (Molecular Devices, FlexStation 3) at 1 s/well.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!